DAIC

FEBRUARY 14, 2025

But nearly halfof all patients with CLTI will die within two years after amputation, which is higher than the mortality rates for breast cancer, colon cancer, and prostate cancer combined. The New England Journal of Medicine published results from that trial leading to the FDA approval of LimFlow in September of 2023.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Cancer Innovation Best Practices 52

HCPLive

DECEMBER 20, 2023

Throughout 2023, interest in the application of CAR-T and other cell therapies to autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies.

Cancer 72

Cancer 72

Stroke Journal

JANUARY 30, 2025

Introduction:Comorbid active cancer among in-hospital onset acute ischemic stroke (IHS) is increasing. The rates of good functional outcome and mortality at discharge in patients with reperfusion therapy were 36%, respectively.Conclusion:One-third of IHS were comorbid active cancer.

Cancer 40

Cancer Hospital Outcomes Strokes 40

Dr. Paddy Barrett

OCTOBER 11, 2024

Between 2020 and 2023, the rates of obesity dropped by about 2% 2. Obesity is the second leading cause of preventable cancers after smoking 9. Anything that reduces obesity has the potential to reduce future risks of any associated cancers. Colorectal Cancer - 46% reduction. Kidney Cancer - 24% reduction.

Obesity 79

Obesity Cancer Dementia Coronary Artery Disease 79

Stroke Journal

JANUARY 30, 2025

Background:Approximately 50% of ischemic strokes in patients with cancer are classified as cryptogenic after standard evaluation. Patients with, compared to those without, a history of cancer were older (71 versus 65 years) and more often White (88% versus 74%) and non-Hispanic (94% versus 90%). versus 1.8

Cancer 40

Cancer Biomarkers Atrial Fibrillation Strokes 40

DAIC

FEBRUARY 6, 2024

a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that the U.S. In July 2023, BridgeBio announced positive results from ATTRibute-CM, reporting a highly statistically significant result, demonstrated by a Win Ratio of 1.8 (p

Cardiomyopathy 105

Cardiomyopathy Cancer Research 105

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

Objective This study aims to explore the effects of the Information-Motivation-Behavioral (IMB) Skills Model on the prevention of Venous Thromboembolism (VTE) in elderly lung cancer patients. The rate of VTE in the intervention group was 2.5%(1/40), 1/40), and that in the control group was 19.5%(8/41).

Cancer 49

Cancer Thrombosis Quality of Life Nursing 49

Dr. Paddy Barrett

JANUARY 16, 2024

Cardiovascular disease, cancer and dementia account for 60% of all deaths in the US. Let’s start with Cancer. Compared to those who had ‘Low’ lifestyle scores, those with ‘Ideal’ scores were 27% less likely to be diagnosed with cancer in the next ten years. The leading causes of death are clear.

Cancer 94

Cancer Dementia Diabetes Cardiovascular Disease 94

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundData on the risk of cardiovascular‐related mortality in patients with cancer are limited.Methods and ResultsThis retrospective cohort study used data from the Osaka Cancer Registry and vital statistics in Japan between 1985 and 2013.

Cancer 40

Cancer Heart Disease Heart Failure Hypertension 40

Dr. Paddy Barrett

FEBRUARY 21, 2025

These stages can range from mild fatty liver infiltration to serious scarring and fibrosis terminating in liver cirrhosis and potentially liver cancer. Type 2 Diabetes When it comes to the increasing the risk of major chronic diseases such as cardiovascular disease, many cancers and dementia, type 2 diabetes plays a huge role.

Obesity 77

Obesity Diabetes Cardiovascular Disease Chronic Disease 77

DAIC

DECEMBER 20, 2023

Image courtesy of MMRI milla1cf Wed, 12/20/2023 - 15:57 December 20, 2023 — Jason R. Jason McCarthy, Ph.D., associate professor of biomedical research and translational medicine at MMRI. McCarthy, Ph.D. McCarthy, Ph.D. Normally after a heart attack, immune cells migrate from the spleen to the heart in response to injury.

Heart Attack 115

Heart Attack Heart attacks Myocardial Infarction Research 115

Circulation

NOVEMBER 11, 2024

Patients were eligible to enter the cohort on the day of cancer diagnosis. Among persons with cancer, OSA diagnosis was associated with increased risk of adverse CVD outcomes (HR: 1.37, 95% CI: 1.36 – 1.38). OSA in persons with cancer increased the risk of heart failure, atrial fibrillation / flutter and myocardial infarction.

Cancer 40

Cancer Cardiovascular Disease Myocardial Infarction Atrial Fibrillation 40

Physiologically Speaking

DECEMBER 20, 2023

In the spring of 2023, I met with a well-respected researcher and oncologist, who wishes to remain anonymous, to ask about mTOR. After some time, we began to talk about research into TOR kinases (Jack was quick to point out that much of contemporary cancer research has moved to immune checkpoint inhibitors). 1 Blagosklonny, M.

Cancer 98

Cancer Physiology Research Laboratory 98

Dr. Paddy Barrett

AUGUST 23, 2024

While I have covered many of these fitness measures individually in previous posts, I wanted to summarise these metrics and how they relate to living longer and preventing major diseases such as cardiovascular disease, cancer and dementia. A higher daily step count is also linked to significantly lower cancer, stroke and heart disease rates.

Exercise 116

Exercise Dementia Cancer Chronic Disease 116

DAIC

JANUARY 12, 2024

a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced that positive results from its Phase 3 ATTRibute-CM study of acoramidis for patients with ATTR-CM were published in the New England Journal of Medicine (NEJM). milla1cf Fri, 01/12/2024 - 13:23 January 12, 2024 — BridgeBio Pharma, Inc. ,

Cardiomyopathy 105

Cardiomyopathy Medicare Cancer Hospital 105

Dr. Paddy Barrett

DECEMBER 12, 2023

There is even emerging evidence that the use of such therapies may even reduce the risk of colorectal cancer by up to 50% 6. 2023 Aug 10;389(6):514-526. 2023 Nov 11. 6 GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity. N Engl J Med.

Obesity 105

Obesity Heart Attack Heart attacks Diet 105

American Heart News - Heart News

NOVEMBER 28, 2023

DALLAS, November 28, 2023 — Cardiovascular disease (CVD) claims more lives than all forms of cancer, yet many women, particularly younger women, remain unaware.[1] 1] Through its Go Red for Women® movement, the American Heart Association, which is devoted.

Cancer 52

Cancer Cardiovascular Disease 52

Stroke Journal

JANUARY 30, 2025

We aimed to compare IS characteristics of patients with non-small cell lung cancer (NSCLC) who received ICIs compared to those who did not.

Cancer 40

Cancer Strokes Stroke Atherosclerosis 40

Dr. Paddy Barrett

APRIL 26, 2024

They are dying less often from the two leading causes of death: Cardiovascular Disease and Cancer. To the point that those with 6 to 7 of the healthy factors in place had essentially eliminated the increased risk of dying from cardiovascular disease or cancer compared to those without type 2 diabetes. J Am Coll Cardiol.

Heart Disease 105

Heart Disease Coronary Artery Disease Diabetes Genetic predisposition 105

The American Journal of Cardiology

DECEMBER 21, 2023

Publication date: Available online 20 December 2023 Source: The American Journal of Cardiology Author(s): Saadia Sherazi, Arpan Patel, Kimberly Hsu, Susan Schleede, Arthur Watts, Scott McNitt, Mehmet Kemal Aktas, Ilan Goldenberg

Sudden Cardiac Death 40

Sudden Cardiac Death Cancer 40

DAIC

JANUARY 8, 2024

Getty Images milla1cf Mon, 01/08/2024 - 11:32 January 8, 2023 — GE HealthCare announced it has entered into an agreement to acquire MIM Software , a global provider of medical imaging analysis and artificial intelligence (AI) solutions for the practice of radiation oncology , molecular radiotherapy, diagnostic imaging, and urology at imaging (..)

Innovation 105

Innovation Technology Patient Care Coronary Artery Disease 105

DAIC

MAY 8, 2024

If inflammation is successfully controlled, diseases – such as arthritis, pulmonary hypertension, Crohn's disease, inflammatory bowel diseases, diabetes, cancer and autoimmune diseases – can be treated more effectively.

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115

Society of Thoracic Surgeons - Surgeon

NOVEMBER 7, 2023

Webinar Innovations in Lung Tumor Localization: The Latest in Bronchoscopy and Molecular Imaging dkaczmarek Tue, 11/07/2023 - 14:49 November 30, 2023 As sublobar resection becomes more prevalent for early stage lung cancer treatment, precise tumor localization has gained greater importance.

Innovation 40

Innovation Webinar Technology Cancer 40

DAIC

FEBRUARY 14, 2025

But nearly halfof all patients with CLTI will die within two years after amputation, which is higher than the mortality rates for breast cancer, colon cancer, and prostate cancer combined. The New England Journal of Medicine published results from that trial leading to the FDA approval of LimFlow in September of 2023.

Hospital 52

Hospital Peripheral Arterial Disease Cancer Innovation 52

Physiologically Speaking

DECEMBER 20, 2023

In the spring of 2023, I met with a well-respected researcher and oncologist, who wishes to remain anonymous, to ask about mTOR. After some time, we began to talk about research into TOR kinases (Jack was quick to point out that much of contemporary cancer research has moved to immune checkpoint inhibitors). 1 Blagosklonny, M.

Cancer 52

Cancer Physiology Research Laboratory 52

Dr. Paddy Barrett

APRIL 12, 2024

Similar patterns have been observed for cardiovascular disease and also cancer. 2023 Apr;7(4):e313-e328. Over a 10-year time frame, compared to 4000 steps, taking 7000 steps every day resulted in a 51% reduction in all-cause mortality. Taking 12,000-a-day steps led to a 65% reduction 5. The relationship is clear. More movement.

Quality of Life 125

Quality of Life Blood Pressure Exercise Chronic Disease 125

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundPrimary pericardial mesothelioma (PMPM) is a rare, aggressive, and lethal form of cancer. We report a case of PMPM highlighting the potential role for multimodal combined therapy.Case reportThe patient is a 62 years old female who had nonspecific syndromes and inconclusive image findings in May 2023.

Chest Pain 52

Chest Pain Ultrasound Cancer Outcomes 52

Journal of Cardiovascular Pharmacology

JULY 31, 2023

ICIs have significantly improved cancer survival in several advanced malignancies and there are currently over 90 different cancer indications for ICIs. Also, high doses of corticosteroids may adversely impact cancer outcomes. Also, high doses of corticosteroids may adversely impact cancer outcomes.

Cancer 40

Cancer Pharmacology Outcomes Article 40

Heart 2023 Conference

APRIL 26, 2022

panel additionally plans to retreat from its 2016 advice to take toddler aspirin for the prevention of colorectal cancer, steering that become groundbreaking on the time. The panel stated greater current statistics had raised questions on the blessings of cancer, and that greater studies become needed.

Heart Attack 52

Heart Attack Heart attacks Cancer Strokes 52

CardiacWire

AUGUST 18, 2024

If these first 10 reductions were in place in 2023, it would have cut $6B in prescription costs, which actually represents a much smaller 22% net reduction due to these drugs’ pre-existing Medicare discounts and rebates.

Medicare 59

Medicare CMS Drug Costs Diabetes 59

Dr. Paddy Barrett

AUGUST 9, 2024

More than heart disease or cancer, the risk of dementia often creates much greater anxiety in the patients I see. 2023 Mar 22. And given that dementia is routinely in the top 5 leading causes of death, this concern is dually warranted. But can dementia be prevented? The answer is yes. 2024 Jul 30:S0140-6736(24)01296-0.

Dementia 115

Dementia Blood Pressure Obesity Cholesterol 115

DAIC

JANUARY 23, 2024

Getty Images milla1cf Tue, 01/23/2024 - 13:38 January 23, 2024 — Sequana Medical NV , a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announced that an independent Data and Safety Monitoring Board (DSMB) approved the start of the randomized cohort in MOJAVE , the US Phase 1/2a study of DSR 2.0

Heart Failure 104

Heart Failure Preserved Ejection Fraction Hypertension Cancer 104

CardiacWire

APRIL 10, 2024

GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundSingle‐cell RNA sequencing is widely used in cancer research and organ development because of its powerful ability to analyze cellular heterogeneity.

Pacemaker 40

Pacemaker Physiology Cancer Research 40

Dr. Smith's ECG Blog

OCTOBER 21, 2023

He also had a history of lung cancer with pneumonectomy and COPD. Here is a subsequent rhythm strip: This confirms sinus rhythm == MY Comment , by K EN G RAUER, MD ( 10/21 /2023 ): == It is often challenging to review the charts of complex cases when you lack a detailed sequential account of events that transpired.

Tachycardia 139

Tachycardia Pulmonary Blood Pressure Blog 139

Dr. Smith's ECG Blog

SEPTEMBER 25, 2024

As I periodically highlight in Dr. Smith's ECG Blog — the entity of “ silent ” MI is much more common than is often appreciated ( See My Comment in the August 19, 2023 post , among many others ). For more on use of Opiates with acute ischemic CP — See the January 6, 2023 post in Dr. Smith's ECG Blog ).

Chest Pain 120

Chest Pain Blog Hospital Tachycardia 120

Dr. Paddy Barrett

JULY 26, 2024

Cancer mortality drops by 14%. Crit Care 27 , 2 (2023). It very clearly does. With just 60 minutes per week of resistance training: The chances of dying from anything (All Cause Mortality) decrease by 15%. Cardiovascular mortality decreases by 19%. If you do more than 60 minutes per week, all-cause mortality drops by 27% 6. Sarcopenia.

Gerontology 106

Gerontology Exercise ICU Cancer 106